Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 2
1995 2
1996 2
1997 1
1998 6
1999 2
2000 2
2001 3
2002 1
2003 1
2005 1
2006 1
2007 1
2009 1
2010 2
2011 6
2012 3
2013 5
2014 14
2015 10
2016 8
2017 7
2018 5
2019 9
2020 8
2021 8
2022 5
2023 10
2024 14
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado D, Carot-Sierra JM, Villalba-Ortiz A, Siddiqi H, Vallejo-Vigo RM, Lara-Romero C, Martín-Fernández M, Fernández-Patón M, Alfaro-Cervello C, Crespo A, Coello E, Merino-Murgui V, Madamba E, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández A, Aguilera V, Monton C, Escudero-García D, Lluch P, Aller R, Loomba R, Romero-Gomez M, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Clin Gastroenterol Hepatol. 2025 Jun;23(7):1183-1193.e5. doi: 10.1016/j.cgh.2024.10.014. Epub 2024 Nov 16. Clin Gastroenterol Hepatol. 2025. PMID: 39551253 Free article.
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score.
Marti-Aguado D, Arnouk J, Liang JX, Lara-Romero C, Behari J, Furlan A, Jimenez-Pastor A, Ten-Esteve A, Alfaro-Cervello C, Bauza M, Gallen-Peris A, Gimeno-Torres M, Merino-Murgui V, Perez-Girbes A, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández-Izquierdo A, Aguilera V, Giesteira B, França M, Monton C, Escudero-García D, Alberich-Bayarri Á, Serra MA, Bataller R, Romero-Gomez M, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Liver Int. 2024 Jan;44(1):202-213. doi: 10.1111/liv.15766. Epub 2023 Oct 30. Liver Int. 2024. PMID: 37904633
Characterizing Hepatitis Delta in Spain and the gaps in its management.
Rodríguez-Tajes S, Palom A, Giráldez-Gallego Á, Moreno A, Urquijo JJ, Rodríguez M, Alvarez-Argüelles M, Diago M, García-Eliz M, Fuentes J, Martínez-Sapiña AM, Castillo P, Casado M, Pérez-Campos E, Muñoz R, Hernández-Conde M, Morillas RM, Granados R, Miquel M, Morillas MJ, García-Retortillo M, Carrión JA, Moreno JM, Montón C, González-Santiago JM, Lorente S, Cabezas J, Mateos B, Vázquez-Rodríguez S, Díaz-Fontenla F, Pinazo JM, Delgado M, Pérez-Palacios D, Horta D, Fernández-Marcos C, López C, Calleja JL, Fernández I, García-Samaniego J, Forns X, Buti M, Lens S. Rodríguez-Tajes S, et al. Among authors: monton c. Gastroenterol Hepatol. 2025 Feb;48(2):502222. doi: 10.1016/j.gastrohep.2024.502222. Epub 2024 Jun 20. Gastroenterol Hepatol. 2025. PMID: 38908682 English, Spanish.
Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor.
Ballester MP, Abril C, Merino V, Alós M, Segarra G, Tosca J, Montón C, Casasus N, Lluch P. Ballester MP, et al. Among authors: monton c. Cancer Diagn Progn. 2024 Sep 1;4(5):623-630. doi: 10.21873/cdp.10373. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238615 Free PMC article.
Markers of ventilator-associated pneumonia.
el-Ebiary M, Soler N, Montón C, Torres A. el-Ebiary M, et al. Among authors: monton c. Clin Intensive Care. 1995;6(3):121-6. Clin Intensive Care. 1995. PMID: 10150559 Review.
128 results